Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13 EUR | +8.33% | -.--% | -.--% |
05-14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
05-14 | Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease | CI |
MarketScreener Editorial Features
- Stock Market
- Equities
- EVT Stock
- EVT Stock
- News Evotec
- MarketScreener Editorial Features